Keck School Faculty

Siamak Daneshmand

Siamak Daneshmand

Associate Professor of Urology (Clinical Scholar)
Director of Clinical Research
Urology
NOR 7416 Health Sciences Campus Los Angeles

Access to high-volume surgeons and the opportunity cost of performing radical prostatectomy by low-volume providersUrol Oncol. 2017 07; 35(7):459. e15-459. e24. . View in PubMed

Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registryUrol Oncol. 2018 08; 36(8):361. e1-361. e6. . View in PubMed

Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United StatesUrol Oncol. 2019 03; 37(3):180. e1-180. e9. . View in PubMed

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma BJU Int. 2020 Sep 27. . View in PubMed

Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines J Urol. 2020 Aug 28; 101097JU0000000000001342. . View in PubMed

Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature Clin Genitourin Cancer. 2020 Aug; 18(4):e473-e477. . View in PubMed

AUTHOR REPLY Urology. 2020 Aug; 142:154. . View in PubMed

Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours Eur Urol Oncol. 2020 Jul 16. . View in PubMed

Bladder Cancer: Advances and Innovations Eur Urol Focus. 2020 Jul 15; 6(4):613-614. . View in PubMed

Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review World J Urol. 2020 Jul 09. . View in PubMed

EDITORIAL COMMENT Urology. 2020 Jun; 140:120-121. . View in PubMed

Detecting Invisible Bladder Cancers With Blue Light Cystoscopy Urology. 2020 May; 139:e8-e9. . View in PubMed

Back to the Future-Moving Forward for Testicular Cancer Survivors JNCI Cancer Spectr. 2020 Apr; 4(2):pkz082. . View in PubMed

Adult genitourinary sarcoma: A population-based analysis of clinical characteristics and survival Urol Oncol. 2020 05; 38(5):334-343. . View in PubMed

Editorial: Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer Curr Opin Urol. 2020 03; 30(2):234. . View in PubMed

Active surveillance for low-risk prostate cancer - in pursuit of a standardized protocol Cent European J Urol. 2020; 73(2):123-126. . View in PubMed

Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma Eur J Surg Oncol. 2019 Oct; 45(10):1983-1992. . View in PubMed

Advanced Testis Cancer Eur Urol Focus. 2019 Sep; 5(5):710-712. . View in PubMed

Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer Urology. 2019 11; 133:157-163. . View in PubMed

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy J Urol. 2019 11; 202(5):1001-1007. . View in PubMed

Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial J Urol. 2019 11; 202(5):920-926. . View in PubMed

Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline J Urol. 2019 08; 202(2):272-281. . View in PubMed

Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy Eur Urol. 2019 08; 76(2):238-243. . View in PubMed

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018 Nat Rev Urol. 2019 06; 16(6):377-386. . View in PubMed

Current controversies on the role of lymphadenectomy for bladder cancer Urol Oncol. 2019 03; 37(3):193-200. . View in PubMed

Extended hospital stay after radical cystectomy with enhanced recovery protocol Can J Urol. 2019 02; 26(1):9654-9659. . View in PubMed

Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer Urol Oncol. 2019 01; 37(1):1-11. . View in PubMed

Correction to: Enhanced Endoscopy in Bladder Cancer Curr Urol Rep. 2019 04 05; 20(5):25. . View in PubMed

Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum J Clin Oncol. 2019 11 20; 37(33):3090-3098. . View in PubMed

Correction to: Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies Curr Urol Rep. 2019 04 04; 20(5):24. . View in PubMed

Enhanced Endoscopy in Bladder Cancer Curr Urol Rep. 2018 Aug 17; 19(10):84. . View in PubMed

Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study World J Urol. 2018 Aug; 36(8):1233-1239. . View in PubMed

Enhanced Recovery After Surgery Pathways: Role and Outcomes in the Management of Muscle Invasive Bladder Cancer Urol Clin North Am. 2018 May; 45(2):229-239. . View in PubMed

Continent Cutaneous Diversion Urol Clin North Am. 2018 Feb; 45(1):55-65. . View in PubMed

Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men Surg Endosc. 2018 11; 32(11):4458-4464. . View in PubMed

Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study J Urol. 2018 05; 199(5):1158-1165. . View in PubMed

Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy Eur Urol Focus. 2018 03; 4(2):245-251. . View in PubMed

Effectiveness of extended pelvic lymphadenectomy in the survival of prostate cancer: a systematic review and meta-analysis Cent European J Urol. 2018; 71(3):262-269. . View in PubMed

Dose dense MVAC prior to radical cystectomy: a real-world experience World J Urol. 2017 Nov; 35(11):1729-1736. . View in PubMed

Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients Clin Genitourin Cancer. 2017 Sep 06. . View in PubMed

90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study World J Urol. 2017 Jun; 35(6):907-911. . View in PubMed

Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional StudyClin Genitourin Cancer. 2017 12; 15(6):689-695. e2. . View in PubMed

Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer J Urol. 2017 03; 197(3 Pt 1):684-689. . View in PubMed

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline J Urol. 2016 Oct; 196(4):1021-9. . View in PubMed

Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer Eur Urol Focus. 2016 Apr; 2(1):92-96. . View in PubMed

Assessment of Urologists' Knowledge of Intraoperative Floppy Iris Syndrome Urology. 2016 11; 97:40-45. . View in PubMed

Editorial Comment J Urol. 2016 06; 195(6):1716. . View in PubMed

A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy J Urol. 2016 Jan; 195(1):53-9. . View in PubMed

Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy World J Urol. 2015 Oct; 33(10):1419-28. . View in PubMed

Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis J Urol. 2015 Aug; 194(2):304-308. . View in PubMed

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review BMC Cancer. 2014 Dec 16; 14:966. . View in PubMed

Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer J Natl Cancer Inst. 2014 Nov; 106(11). . View in PubMed

Enhanced recovery protocol after radical cystectomy for bladder cancer J Urol. 2014 Jul; 192(1):50-5. . View in PubMed

Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review Eur Urol. 2014 Jul; 66(1):120-37. . View in PubMed

A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence Clin Cancer Res. 2014 Apr 01; 20(7):1978-89. . View in PubMed

Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder Urol Oncol. 2014 Apr; 32(3):230-42. . View in PubMed

Enhanced recovery pathway following radical cystectomy Curr Opin Urol. 2014 Mar; 24(2):135-9. . View in PubMed

Urol Oncol. 2014 Feb; 32(2):117-27. . View in PubMed

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patientsUrol Oncol. 2014 Jan; 32(1):52. e1-9. . View in PubMed

Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes Patient Relat Outcome Meas. 2014; 5:63-70. . View in PubMed

Editorial comment Urology. 2013 Dec; 82(6):1346. . View in PubMed

Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis Eur Urol. 2013 Nov; 64(5):837-45. . View in PubMed

Active surveillance is the preferred approach to clinical stage I testicular cancer J Clin Oncol. 2013 Oct 01; 31(28):3490-3. . View in PubMed

Editorial comment J Urol. 2013 Sep; 190(3):927. . View in PubMed

Determining the role of cystectomy for high-grade T1 urothelial carcinoma Urol Clin North Am. 2013 May; 40(2):233-47. . View in PubMed

Conversion from incontinent conduit to continent cutaneous reservoir after renal transplant Urology. 2013 May; 81(5):1086-9. . View in PubMed

Editorial comment J Urol. 2013 Apr; 189(4):1318-9. . View in PubMed

Androgen deprivation therapy: evidence-based management of side effects BJU Int. 2013 Apr; 111(4):543-8. . View in PubMed

A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer BJU Int. 2013 Feb; 111(2):240-8. . View in PubMed

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol. 2012 Dec; 30(6):807-14.. View in PubMed

Contemporary management of postchemotherapy testis cancer Eur Urol. 2012 Nov; 62(5):867-76. . View in PubMed

Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy Eur Urol. 2012 Oct; 62(4):671-6. . View in PubMed

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol. 2012 Sep; 62(3):523-33. . View in PubMed

Editorial comment Urology. 2012 Sep; 80(3):639; author reply 639-40. . View in PubMed

Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection Ann Surg Oncol. 2012 Jul; 19(7):2388-93. . View in PubMed

Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment Eur Urol. 2012 Feb; 61(2):237-42. . View in PubMed

Colocalycostomy for repair of ureterojejunal fistula Urology. 2012 Feb; 79(2):e12-4. . View in PubMed

Editorial comment Urology. 2012 Feb; 79(2):481; author reply 481-2. . View in PubMed

Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics Front Endocrinol (Lausanne). 2012; 3:182. . View in PubMed

Chemoresponsive liver hemangioma in a patient with a metastatic germ cell tumor J Clin Oncol. 2011 Dec 10; 29(35):e842-4. . View in PubMed

Androgen-producing testicular germ cell tumors J Clin Oncol. 2011 Jul 20; 29(21):e634-5. . View in PubMed

Evaluation and Preservation of Fertility in Patients with Testicular Cancer J Adolesc Young Adult Oncol. 2011 Mar; 1(1):25-9. . View in PubMed

Editorial comment Urology. 2010 Oct; 76(4):1001. . View in PubMed

Distinctive morphology of renal cell carcinomas in tuberous sclerosis Int J Surg Pathol. 2010 Oct; 18(5):409-18. . View in PubMed

Application of the Yang-Monti channel in adult continent cutaneous urinary diversion Urology. 2008 Oct; 72(4):828-31. . View in PubMed

Bilateral segmental testicular infarction ScientificWorldJournal. 2007 Feb 19; 7:779-83. . View in PubMed

Evolving treatment paradigms for locally advanced and metastatic prostate cancer Expert Rev Anticancer Ther. 2006 Nov; 6(11):1639-51. . View in PubMed

A critical analysis of perioperative mortality from radical cystectomy J Urol. 2006 Mar; 175(3 Pt 1):886-9; discussion 889-90. . View in PubMed

Adrenal myelolipoma: diagnosis and management Urol J. 2006; 3(2):71-4. . View in PubMed

Current clinical trials in renal cell carcinoma Urol Oncol. 2005 Jul-Aug; 23(4):289-92. . View in PubMed

EphB4 expression and biological significance in prostate cancer Cancer Res. 2005 Jun 01; 65(11):4623-32. . View in PubMed

Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue Urology. 2005 May; 65(5):1008-12. . View in PubMed

Angiomyolipoma of the kidney: expanding disease spectrum demonstrated by 3 cases Appl Immunohistochem Mol Morphol. 2004 Sep; 12(3):277-83. . View in PubMed

Adenomatous polyp of the verumontanum causing bladder outlet obstruction ScientificWorldJournal. 2004 Jun 07; 4 Suppl 1:89-91. . View in PubMed

Continent right colon reservoir using a cutaneous appendicostomy Urology. 2004 Mar; 63(3):577-80; discussion 580-1. . View in PubMed

Benign retroperitoneal schwannoma: a case series and review of the literature Urology. 2003 Dec; 62(6):993-7. . View in PubMed

Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience Cancer. 2003 Jul 01; 98(1):55-60. . View in PubMed

Colourachal fistula in an adult presenting with feculent umbilical drainage J Urol. 2003 Jul; 170(1):184. . View in PubMed

Endoscopic management of renal hemangioma J Urol. 2002 Feb; 167(2 Pt 1):488-9. . View in PubMed

Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after one or more failed attempts Fertil Steril. 2001 Sep; 76(3):538-42. . View in PubMed

Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University where he established the Section of Urologic Oncology as a center of excellence for treatment of bladder and testis cancers. He was recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an associate professor of urology with clinical scholar designation and serves as director of clinical research as well as the urologic oncology fellowship director. Dr. Daneshmand’s main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience in urinary diversion and reconstruction following surgical removal of the bladder (radical cystectomy) as well as nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testis cancer. He is one of the highest volume surgeons for this disease on the west coast. He has been selected as one of “True Experts” in the Testicular Cancer Resource Center web site. He also has extensive experience in the management of advanced kidney cancers with vena caval tumor thrombus involvement, as well as prostate cancer, retroperitoneal sarcomas and surgeries requiring replacement of the great vessels. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Doctors” for several years. He is an active member of the Society of Urologic Oncology, has presented over 150 abstracts at scientific meetings and has authored over 120 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.
Powered by SC CTSI
Go to Top